glp 1 vs glp 1/gip GLP-1 & GIP Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) Designing a dual GLP-1R/GIPR agonist

Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy

The pharmaceutical companies extensive marketing of these drugs (with Novo Nordisk and Eli Lilly commanding market dominance and generating billions in annual revenue) created widespread exposure among both diabetes patients and those seeking weight loss

doi:10.1056/NEJMsr1606602

3 Paste your code at checkout Look for the "Promo Code" or "Coupon Code" field on the payment screen

Am I a Candidate for a GLP-1 or Dual GIP/GLP-1 Agonist

69% of patients achieved more than 10% weight loss compared to 9% on placebo